Capricor Therapeutics
CAPR
#7735
Rank
A$0.67 B
Marketcap
A$11.57
Share price
21.91%
Change (1 day)
13.59%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -A$0.18 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.15 Billion a decrease over its 2024 earnings that were of -A$56.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.18 Billion16.42%
2025 -A$0.15 Billion159.57%
2024 -A$56.47 Million81.57%
2023 -A$31.11 Million-23.2%
2022 -A$40.5 Million44.93%
2021 -A$27.94 Million46.61%
2020 -A$19.06 Million78.71%
2019 -A$10.67 Million-49.7%
2018 -A$21.2 Million-724.78%
2017 A$3.39 M-112.93%
2016 -A$26.25 Million46.27%
2015 -A$17.95 Million106.82%
2014 -A$8.68 Million-48.41%
2013 -A$16.82 Million977.23%
2012 -A$1.57 Million-77.11%
2011 -A$6.82 Million-22.35%
2010 -A$8.79 Million-20.17%
2009 -A$11.01 Million-41.17%
2008 -A$18.7 Million41.05%
2007 -A$13.26 Million1098.87%
2006 -A$1.11 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.25 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.11 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.16 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$8.71 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$20.82 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA